Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-14

Clinical Trial Update: Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 clinical trial evaluating the efficacy and safety of TTYP01 tablets in adolescents and children with autism spectrum di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TTYP01

Snippet

Sponsor: Shanghai Auzone Biological Technology Co., Ltd. | Conditions: Autism Spectrum Disorder (ASD) | Phase 2 | Status: RECRUITING